Cargando…
Adverse Impact of DNA Methylation Regulatory Gene Mutations on the Prognosis of AML Patients in the 2017 ELN Favorable Risk Group, Particularly Those Defined by NPM1 Mutation
The 2017 ELN risk stratification has been widely adopted, but some studies have suggested the outcomes are heterogenous within the ELN risk groups and may be affected by other co-existing genetic mutations. This study evaluated the impact of DNA methylation regulatory gene (TET2, IDH1/2, DNMT3A, SET...
Autores principales: | Yu, James, Sun, Jingxin, Du, Yuan, Patel, Rushang, Varela, Juan Carlos, Mori, Shahram, Chang, Chung-Che |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227437/ https://www.ncbi.nlm.nih.gov/pubmed/34072516 http://dx.doi.org/10.3390/diagnostics11060986 |
Ejemplares similares
-
Bone Marrow Clonogenic Myeloid Progenitors from NPM1-Mutated AML Patients Do Not Harbor the NPM1 Mutation: Implication for the Cell-Of-Origin of NPM1+ AML
por: Diaz de la Guardia, Rafael, et al.
Publicado: (2020) -
Significance of NPM1 Gene Mutations in AML
por: Hindley, Andrew, et al.
Publicado: (2021) -
The antagonistic duality of NPM1 mutations in AML
por: Khan, Irum, et al.
Publicado: (2022) -
NPM 1 Mutations in AML—The Landscape in 2023
por: Sharma, Naman, et al.
Publicado: (2023) -
Targeted therapy in NPM1-mutated AML: Knowns and unknowns
por: Wang, Rong, et al.
Publicado: (2022)